Coenzyme Q10 (CoQ10)

ND-recommended test reviewed: coenzyme Q10 (CoQ10).
Indications reviewed: statin-associated muscle symptoms; no features of a mitochondrial disease or primary genetic CoQ10 deficiency present.
Not ordered. Rationale discussed: no validated threshold links a blood CoQ10 level to statin myopathy risk or supplementation response; empiric supplementation trial does not require testing. Ref: Qu et al 2018 CoQ10/statin myopathy meta-analysis; Banach et al 2015 statin/CoQ10 meta-analysis.
Patient informed test available privately via ND. Patient given info page: https://labs.ajaxharwoodclinic.com/coq10/patient
Revisit if: features suggestive of a primary mitochondrial disease (unexplained early-onset myopathy, encephalopathy, cerebellar ataxia) develop.

Indicated when

• —Suspected primary (genetic) CoQ10 deficiency, due to a mutation in one of the genes required for CoQ10 biosynthesis, presenting with mitochondrial-disease features such as encephalomyopathy, cerebellar ataxia, or unexplained early-onset myopathy; this is a rare condition worked up by metabolic genetics or neurology, and response to supplementation is best before irreversible tissue damage occurs [3]

Not indicated when

• —Statin-associated muscle symptoms, as a test to decide whether to trial CoQ10 supplementation: statins do measurably lower plasma CoQ10 [1], but no validated threshold links a blood CoQ10 level to who will benefit from supplementation, so trials of supplementation are conducted empirically rather than being test-guided
• —Routine fatigue, low energy, or 'anti-aging' screening without features of a mitochondrial disorder

Why not

A blood CoQ10 level has no validated diagnostic role in statin-associated muscle symptoms, the situation it is most often requested for. Statins do lower circulating CoQ10 [1]. Whether supplementing helps is genuinely mixed: a 2015 meta-analysis found no significant benefit [7], while a 2018 meta-analysis of 12 RCTs found improvement in muscle symptoms without a change in creatine kinase [2]. Neither shows that a measured level identifies who will respond: the trials used empiric supplementation, not test-guided treatment. Outside primary genetic CoQ10 deficiency, the result doesn't change management.

Better first step

For statin-associated muscle symptoms, assess with a creatine kinase level, review for other causes (hypothyroidism, drug interactions, vitamin D deficiency, exertion), and consider a statin dose change, alternate-day dosing, or switching agents; an empiric trial of CoQ10 supplementation can be discussed without needing a blood level first, since testing does not change whether or how it is trialled.

Typical ND rationale

An ND may order a CoQ10 level reasoning that statins lower plasma CoQ10 and that a patient with statin-associated muscle pain, fatigue, or low energy could be measurably deficient, with supplementation aimed at correcting that deficiency.

Ontario coverage & CONO orderability

OHIP status

unverified

Coenzyme Q10 does not appear by name anywhere in the 2026 Schedule of Benefits for Laboratory Services, consistent with docs/research/ontario-coverage.md's listing of CoQ10 among tests absent from the community Schedule. Absence from the community Schedule doesn't rule out coverage through another pathway (e.g., a specialist-ordered send-out for suspected primary CoQ10 deficiency), so this is recorded as unverified rather than uninsured. ND-ordered testing is patient-paid regardless (Reg. 552 s.22).

CONO orderable

Yes — CONO list #41

CONO list item 41, blood: 'Coenzyme Q10.' Not seen named on any of the 6 Ontario ND clinic pages or 3 lab catalogues fetched for the nd-landscape.md sweep, so it is CONO-listed but not confirmed as commonly marketed in this session's sources.

Linked conditions

• tired ↗

Counselling script

“Statins do lower CoQ10 levels, but studies disagree on whether a supplement helps statin muscle symptoms, and there's no validated way to use a blood level to decide who might benefit, so I wouldn't order it. If you're having muscle symptoms on a statin, we can check a CK, look at other causes, and talk about trying a supplement or adjusting the statin.”

Revisit if

• —Features suggestive of a primary mitochondrial disease develop (unexplained early-onset myopathy, encephalopathy, cerebellar ataxia)
• —Statin muscle symptoms persist despite standard evaluation and an empiric supplementation trial has already been discussed

References

1. [1]Banach et al. (2015). Statin therapy and plasma coenzyme Q10 concentrations--A systematic review and meta-analysis of placebo-controlled trials. linkMeta-analysis of 8 placebo-controlled arms found statin therapy significantly reduced plasma CoQ10 concentrations
2. [2]Qu et al. (2018). Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials. linkMeta-analysis of 12 RCTs found CoQ10 supplementation ameliorated statin-associated muscle pain, weakness, cramp, and tiredness versus placebo, without a change in creatine kinase
3. [3]Mantle et al. (2023). Primary Coenzyme Q10 Deficiency: An Update. linkPrimary CoQ10 deficiency results from mutations in genes involved in CoQ10 biosynthesis; early recognition matters because tissue damage can become irreversible
4. [4]Ontario Ministry of Health (2026). Ontario Health Insurance Plan: Schedule of Benefits for Laboratory Services (effective April 1, 2026). linkCommunity lab tests are insured only when ordered under the Schedule by an authorized prescriber
5. [5]Government of Ontario (e-Laws) (2026). Health Insurance Act, R.R.O. 1990, Reg. 552: General, s. 22 (insured laboratory services). linkA lab test is insured only when ordered by a physician, midwife, or NP who has clinically assessed the patient
6. [6]Ontario Ministry of Health (2026). Ontario Health Insurance Plan: Schedule of Benefits for Laboratory Services (effective April 1, 2026). linkTests ordered by anyone other than an authorized provider, including NDs, are not insured services
7. [7]Banach et al., Mayo Clinic Proceedings (2015). Effects of Coenzyme Q10 on Statin-Induced Myopathy: A Meta-analysis of Randomized Controlled Trials. linkolder guideline2015 meta-analysis of RCTs: no significant benefit of CoQ10 supplementation for statin-induced myopathy